Solana Biofuels Limited
Southern Online Bio Technologies the name of the Company has been Changed to Southern Online Bio Technologies Limited on 31st March 2004 to reflect the new line of business in which the Company has ventured i.e. manufacture of Biodiesel. Currently the Companys shares are listed at BSE.
- Market Cap ₹ 5.49 Cr.
- Current Price ₹ 0.93
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 8.13
- Dividend Yield 0.00 %
- ROCE 0.31 %
- ROE -2.99 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.11 times its book value
- Company is expected to give good quarter
- Debtor days have improved from 44.4 to 20.1 days.
- Company's working capital requirements have reduced from 274 days to 126 days
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -10.7% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
201 | 247 | 221 | 124 | 6 | 3 | 2 | 2 | 2 | 15 | 67 | 147 | |
201 | 248 | 221 | 155 | 107 | 3 | 81 | 1 | 2 | 18 | 66 | 144 | |
Operating Profit | 1 | -1 | 0 | -31 | -101 | -1 | -79 | 1 | 0 | -3 | 2 | 4 |
OPM % | 0% | -0% | 0% | -25% | -1,570% | -27% | -3,779% | 30% | 13% | -17% | 2% | 3% |
0 | 0 | 0 | 0 | 3 | 1 | 335 | 0 | 0 | 1 | 0 | 0 | |
Interest | 18 | 20 | 6 | 34 | 23 | 6 | 0 | 0 | 0 | 1 | 6 | 2 |
Depreciation | 8 | 12 | 2 | 11 | 10 | 10 | 10 | 0 | 0 | 3 | 4 | 4 |
Profit before tax | -25 | -32 | -7 | -75 | -131 | -16 | 246 | 0 | 0 | -5 | -7 | -2 |
Tax % | -32% | -64% | -32% | 1% | 2% | -383% | 32% | 8% | 0% | 0% | 0% | -36% |
-17 | -12 | -5 | -75 | -134 | 45 | 166 | 0 | 0 | -5 | -7 | -1 | |
EPS in Rs | -3.33 | -1.98 | -0.85 | -12.78 | -22.70 | 7.70 | 28.11 | 0.10 | 0.05 | -1.14 | -1.61 | -0.25 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | -5% |
5 Years: | 134% |
3 Years: | 290% |
TTM: | 119% |
Compounded Profit Growth | |
---|---|
10 Years: | 7% |
5 Years: | % |
3 Years: | % |
TTM: | 85% |
Stock Price CAGR | |
---|---|
10 Years: | -12% |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -6% |
3 Years: | -11% |
Last Year: | -3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 51 | 59 | 59 | 59 | 59 | 59 | 0.00 | 45 | 45 | 45 | 45 | 45 |
Reserves | -32 | -51 | -56 | -132 | -266 | -220 | 49 | 5 | 5 | -0 | -7 | -8 |
143 | 184 | 243 | 340 | 340 | 367 | 8 | 10 | 33 | 66 | 127 | 171 | |
54 | 71 | 76 | 19 | 36 | 19 | 4 | 6 | 3 | 11 | 7 | 7 | |
Total Liabilities | 217 | 263 | 322 | 286 | 169 | 224 | 61 | 66 | 87 | 123 | 172 | 214 |
126 | 112 | 138 | 129 | 118 | 107 | 52 | 52 | 51 | 49 | 80 | 76 | |
CWIP | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 4 | 22 | 44 | 50 | 78 |
Investments | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
91 | 149 | 185 | 156 | 51 | 117 | 9 | 11 | 14 | 30 | 43 | 60 | |
Total Assets | 217 | 263 | 322 | 286 | 169 | 224 | 61 | 66 | 87 | 123 | 172 | 214 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-13 | -45 | 0 | -96 | 24 | -28 | 274 | 2 | -6 | 5 | -11 | ||
-3 | -0 | 0 | -2 | 1 | 1 | 46 | -3 | -18 | -22 | -40 | ||
20 | 41 | 0 | 98 | -25 | 27 | -320 | 2 | 23 | 18 | 53 | ||
Net Cash Flow | 4 | -5 | 0 | -1 | 0 | -0 | -0 | 1 | -0 | -0 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 65 | 86 | 110 | 307 | 281 | 614 | 297 | 276 | 409 | 67 | 46 | 20 |
Inventory Days | 73 | 53 | 93 | 22 | 642 | 495 | 123 | 84 | ||||
Days Payable | 92 | 107 | 122 | 26 | 757 | 102 | 8 | 7 | ||||
Cash Conversion Cycle | 47 | 31 | 81 | 303 | 166 | 614 | 297 | 276 | 409 | 461 | 161 | 96 |
Working Capital Days | 61 | 87 | 139 | 367 | 167 | 3,520 | 438 | 109 | 1,406 | 504 | 193 | 126 |
ROCE % | -4% | -7% | -1% | -16% | -54% | -6% | 187% | 1% | 0% | -5% | -1% | 0% |
Documents
Announcements
-
Board Meeting Outcome for Outcome Of Board Meeting
2d - Solana Biofuels reports FY25 audited loss of Rs.111.12 lakhs; auditors give unmodified opinion.
-
Financial Results For The Period Ended 31.03.2025
2d - Solana Biofuels reports FY25 audited results: Rs.14,742L revenue, Rs.111L net loss, auditor unmodified opinion.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
24 May - Annual Secretarial Compliance Report submitted for year ended March 31, 2025.
-
Board Meeting Intimation for To Consider And Approve The Audited Financial Results
22 May - Board meeting on May 29 to approve FY25 Q4 and annual audited financial results.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 17 Apr